Internal medicine, Endocrinology, Pharmacology, Receptor and Benzodiazepine are his primary areas of study. He has researched Endocrinology in several fields, including Cholecystokinin, Schizophrenia and Epipregnanolone. His studies in Pharmacology integrate themes in fields like Metabolite, Convulsant, Binding site and Diazepam binding.
As part of the same scientific family, Steven M. Paul usually focuses on Receptor, concentrating on Central nervous system and intersecting with Seizure threshold. He interconnects Diazepam, Endogeny, Learned helplessness, Receptor complex and Neuroscience in the investigation of issues within Benzodiazepine. His GABAA receptor research includes elements of Inverse agonist, Pentobarbital, Lorazepam and In vivo.
Steven M. Paul spends much of his time researching Pharmacology, Internal medicine, Endocrinology, Receptor and GABAA receptor. The various areas that Steven M. Paul examines in his Pharmacology study include Diazepam binding, Benzodiazepine, Binding site and Convulsant. The Benzodiazepine study which covers Receptor complex that intersects with Ionophore.
His Endocrinology study combines topics from a wide range of disciplines, such as Homovanillic acid and Muscimol. His Receptor study incorporates themes from Cell biology, Neuroscience, In vivo and Mechanism of action. His GABAA receptor research focuses on Pentobarbital and how it relates to Barbiturate.
His primary areas of study are Internal medicine, Endocrinology, Pharmacology, Genetics and GABAA receptor. His work in the fields of Muscimol, Cerebral cortex, Locus coeruleus and Tyrosine hydroxylase overlaps with other areas such as In situ hybridization. His biological study spans a wide range of topics, including Long-term potentiation, Epipregnanolone, Pregnanolone and Allopregnanolone.
He combines subjects such as Benzodiazepine, Mechanism of action, NMDA receptor, Glutamate receptor and Serotonin reuptake with his study of Pharmacology. GABAA receptor is a subfield of Receptor that he tackles. His work in the fields of Receptor, such as Agonist, Neurotransmission and Neuroactive steroid, intersects with other areas such as Monozygotic twin.
Steven M. Paul focuses on Endocrinology, Internal medicine, GABAA receptor, Epipregnanolone and Receptor. His Endocrinology research is multidisciplinary, incorporating perspectives in Antibody, Benzodiazepine, Diazepam and Anxiolytic. His Internal medicine research incorporates themes from Ether and Polyclonal antibodies.
The study incorporates disciplines such as Cerebral cortex and Pentobarbital in addition to GABAA receptor. He focuses mostly in the field of Epipregnanolone, narrowing it down to matters related to Tetrahydrodeoxycorticosterone and, in some cases, Allopregnanolone and Pregnanolone. His work carried out in the field of Receptor brings together such families of science as Alpha, Pregnane and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Opiant Pharmaceuticals
University of California, Davis
National Institutes of Health
National Institutes of Health
University of California, San Francisco
National Institutes of Health
University of North Carolina at Chapel Hill
United States Department of Veterans Affairs
Tufts University
Tufts University